1. D’souza HS, Dsouza SA, Menezes G, Venkatesh T. Diagnosis, evaluation, and treatment of lead poisoning in general population. Indian J Clin Biochem. 2011;26:197–200. [PMC free article] [PubMed] [Google Scholar]
2. ChemID plus . Lead and lead compounds. Bethesda, MD: U.S. National Library of Medicine; 2005. [Google Scholar]
4. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress Part. I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 2001;1:529–539. [PubMed] [Google Scholar]
5. Gidlow DA. In-depth review: lead toxicity. Occup Med. 2015;65:348–356. [PubMed] [Google Scholar]
6. Chandran L, Cataldo R. Lead poisoning: basics and new developments. Pediatr Rev. 2010;31:399–405. [PubMed] [Google Scholar]
7. Multani A. Lead contamination of drinking water in India due to PVC pipes. LEAD Action News. 2001;10(1):12–15. [Google Scholar]
8. Kianoush S, Sadeghi M, Balali-Mood M. Recent advances in the clinical management of lead poisoning. Acta Med Iran. 2015;53:327–336. [PubMed] [Google Scholar]
9. Sanborn MD, Abelsohn A, Campbell M, Weir E. Identifying and managing adverse environmental health effects: 3. Lead exposure. CMAJ. 2002;166:1287–1292. [PMC free article] [PubMed] [Google Scholar]
10. Agency for Toxic Substances and Disease Registry Case Studies in Environmental Medicine (CSEM) Lead Toxicity. Atlanta: US Department of Health and Human Services, Public Health Service; 2010. [Google Scholar]
11. Why barns are red: the health risks from lead and their prevention. A resource manual to promote public awareness. Metropolitan Toronto Teaching Health Units and the South Riverdale Community Health Centre, Toronto; 1995.
12. Bellinger D, Leviton A, Rubinovitz M, Needleman H, Waternaux C. Longitudinal analysis of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med. 1987;316:1037–1043. [PubMed] [Google Scholar]
13. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect. 1997;105:928–938. [PMC free article] [PubMed] [Google Scholar]
14. Karri SK, Saper RB, Kales SN. Lead encephalopathy due to traditional medicines. Curr Drug Saf. 2008;3:54–59. [PMC free article] [PubMed] [Google Scholar]
15. Barbosa F, Jr, Tanus-Santos JE, Gerlach RF, Parsons PJ. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect. 2005;113:1669–1674. [PMC free article] [PubMed] [Google Scholar]
16. Patrick L. Lead toxicity Part. II: The role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev. 2006;11:114. [PubMed] [Google Scholar]
17. Centers for Disease Control and Prevention/National Center for Environmental Health. Publications List; Nov 25, 2011.
18. Update: blood lead levels-United States, 1991–1994. Morbidity and Mortality Weekly Report. 1997;46:141–6. [PubMed]
19. Advisory committee on childhood lead poisoning prevention (ACCLPP). CDC; 2012. [PubMed]
20. Occupational safety and health guideline for inorganic lead. CDC: U.S. Department of Health and Human Services; 1988.
21. Patocka J. Organic lead toxicology. Acta Med. 2008;51:209–213. [PubMed] [Google Scholar]
22. Nevin R. Understanding international crime trends: the legacy of preschool lead exposure. Environ Res. 2007;104:315–336. [PubMed] [Google Scholar]
23. American Academics of Pediatrics Lead exposure in children: prevention, detection and management. Pediatrics. 2005;116:1036–1046. [PubMed] [Google Scholar]
24. Wetmur JG. Influence of the common human δ-aminolevulinate dehydratase polymorphism on lead body burden. Environ Health Perspect. 1994;102:215–219. [PMC free article] [PubMed] [Google Scholar]
25. Strayer DS, Rubin E. Environmental and nutritional pathology. In: Rubin R, Strayer DS, editors. Rubins pathology; Clinicopathologic foundations of medicine. 5. Philadelphia: Lippincot; 2008. pp. 253–284. [Google Scholar]
26. Ibrahim NM, Eweis EA, El-Beltagi HS, Abdel- Mobdy YE. Effect of lead acetate toxicity on experimental male albino rat. Asian Pac J Trop Biomed. 2012;2:41–46. [PMC free article] [PubMed] [Google Scholar]
27. Kosnett MJ. Lead. In: Olson KR, editor. Poisoning and drug overdose. 5. New York: McGraw Hill Professional; 2006. [Google Scholar]
28. Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS, et al. Recommendations for medical management of adult lead exposure. Environ Health Perspect. 2007;115:463–471. [PMC free article] [PubMed] [Google Scholar]
29. Grant LD. Lead and compounds. In: Lippmann M, editor. Environmental toxicants: human exposures and their health effects. 3. Hoboken, NJ: Wiley; 2008. pp. 757–809. [Google Scholar]
30. Flora SJ. Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med. 2011;51:257–281. [PubMed] [Google Scholar]
31. Flora SJS. Nutritional components modify metal absorption, toxic response and chelation therapy. J Nutr Environ Med. 2002;12:53–67. [Google Scholar]
32. Hultberg B, Andersson A, Isaksson A. Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol. Toxicology. 2001;156:93–100. [PubMed] [Google Scholar]
33. Ahamed M, Siddiqui MKJ. Low level lead exposure and oxidative stress: current opinions. Clin Chim Acta. 2007;383:57–64. [PubMed] [Google Scholar]
34. Flora SJ, Saxena G, Mehta A. Reversal of lead-induced neuronal apoptosis by chelation treatment in rats: role of reactive oxygen species and intracellular Ca2+ J Pharmacol Exp Ther. 2007;322:108–116. [PubMed] [Google Scholar]
35. Corradi M, Goldoni M, Sabbadini M. Acute lead poisoning: a singular case of haemolytic anemia and lead colic. Med Lav. 2011;102:243–249. [PubMed] [Google Scholar]
36. Kiziler AR, Aydemir B, Onaran I, Alici B, Ozkara H, Gulyasar T, et al. High levels of cadmium and lead in seminal fluid and blood of smoking men are associated with high oxidative stress and damage in infertile subjects. Biol Trace Elem Res. 2007;120:82–91. [PubMed] [Google Scholar]
37. Kasperczyk S, Birkner E, Kasperczyk A, Zalejska-Fiolka J. Activity of superoxide dismutase and catalase in people protractedly exposed to lead compounds. Ann Agric Environ Med. 2004;11:291–296. [PubMed] [Google Scholar]
38. Oyagbemi AA, Omobowale TO, Akinrinde AS, Saba AB, Ogunpolu BS, Daramola O. Lack of reversal of oxidative damage in renal tissues of lead acetate treated rats. Environ Toxicol. 2015;30:1235–1243. [PubMed] [Google Scholar]
39. Vaziri ND, Khan M. Interplay of reactive oxygen species and nitric oxide in the pathogenesis of experimental lead-induced hypertension. Clin Exp Pharmacol Physiol. 2007;34:920–925. [PubMed] [Google Scholar]
40. Roy A, Queirolo E, Peregalli F, Manay N, Martinez G, Kordas K. Association of blood lead levels with urinary F2-8α isoprostane and 8-hydroxy-2-deoxy-guanosine concentrations in first-grade Uruguayan children. Environ Res. 2015;140:127–135. [PMC free article] [PubMed] [Google Scholar]
41. Assi MA, Hezmee MNM, Haron AW, Sabri MYM, Rajion MA. The detrimental effects of lead on human and animal health. Vet World. 2016;9:660–671. [PMC free article] [PubMed] [Google Scholar]
42. White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol. 2007;225:1–27. [PubMed] [Google Scholar]
43. Baranowska-Bosiacka I, Gutowska I, Rybicka M, Nowacki P, Chlubek D. Neurotoxicity of lead. Hypothetical molecular mechanisms of synaptic function disorders. Neurol Neurochir Pol J. 2012;46:569–578. [PubMed] [Google Scholar]
44. Vij AG, Dhundasi SA. Hemopoietic, hemostatic and mutagenic effects of lead and possible prevention by zinc and vitamin C. Al Ameen J Med Sci. 2009;2:27–36. [Google Scholar]
45. Ahamed M, Verma S, Kumar A, Siddiqui MKJ. Environmental exposure to lead and its correlation with biochemical indices in children. Sci Total Environ. 2005;46:48–55. [PubMed] [Google Scholar]
46. Cleveland LM, Minter ML, Cobb KA, Scott AA, German VF. Lead hazards for pregnant women and children. Am J Nurs. 2008;108:40–49. [PubMed] [Google Scholar]
47. Fujita H, Nishitani C, Ogawa K. Lead, chemical porphyria, and heme as a biological mediator. Tohoku J Exp Med. 2002;196:53–64. [PubMed] [Google Scholar]
48. Casaret LJ, Klaassen CD, Doull J, editors. Toxic effects of metals. Casarett and Doull’s toxicology: the basic science of poisons. 7. New York: McGraw Hill Professional; 2007. [Google Scholar]
49. Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit. 2006;12:RA57–RA65. [PubMed] [Google Scholar]
50. Lidsky TI, Schneider JS. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain. 2003;126:5–19. [PubMed] [Google Scholar]
51. Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res. 1999;24:595–600. [PubMed] [Google Scholar]
52. Kosnett MJ. Lead. In: Brent J, editor. Critical care toxicology: diagnosis and management of the critically poisoned patient. Houston: Gulf Professional Publishing; 2005. p. 822. [Google Scholar]
53. Brent JA. Review of medical toxicology. J Clin Toxicol. 2006;44:355. [Google Scholar]
54. Mtui E, Gruener G, FitzGerald MJT. Clinical neuroanatomy and neuroscience. Philadelphia, PA: Elsevier Health Sciences; 2011. [Google Scholar]
55. Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009;24:15–46. [PMC free article] [PubMed] [Google Scholar]
56. Pearson HA, Schonfeld DJ. Lead. In: Rudolph CD, editor. Rudolph’s pediatrics. 21. New York: McGraw-Hill Professional; 2003. pp. 1016–1056. [Google Scholar]
57. Park SK, O’Neill MS, Vokonas PS, Sparrow D, Wright RO, Coull B, et al. Air pollution and heart rate variability: effect modification by chronic lead exposure. Epidemiology. 2008;19:111–120. [PMC free article] [PubMed] [Google Scholar]
58. Bellinger DC. Very low lead exposures and children’s neurodevelopment. Curr Opin Pediatr. 2008;20:172–177. [PubMed] [Google Scholar]
59. Brunton LL, Goodman LS, Blumenthal D, Buxton I, Parker KL, editors. Goodman and Gillmans manual of pharmocology and theraupetics. New York: McGraw Hill Professional; 2007. [Google Scholar]
60. Winneke G, Brockhaus A, Ewers U, Kramer U, Neuf M. Results from the European multicenter study on lead neurotoxicity in children: implications for risk assessment. Neurotoxicol Teratol. 1990;12:553–559. [PubMed] [Google Scholar]
61. International Programme on Chemical Safety (IPCS) Evaluation—monograph on lead, inorganic. Geneva: World Health Organization; 2007. [Google Scholar]
62. National Poisons Information Service (NPIS) US. Lead. TOXBASE, Health Protection Agency; 2010.
63. Billings RJ, Berkowitz RJ, Watson G. Teeth. Pediatrics. 2004;113:1120–1127. [PubMed] [Google Scholar]
64. Triebig G, Weltle D, Valentin H. Investigations on neurotoxicity of chemical substances at the workplace. V. Determination of the motor and sensory nerve conduction velocity in persons occupationally exposed to lead. Int Arch Occup Environ Health. 1984;53:189–203. [PubMed] [Google Scholar]
65. Davis JM, Svendsgaard DJ. Nerve conduction velocity and lead: a critical review and meta-analysis. In: Johnson BL, Anger WK, Durao A, Xinteras C, editors. Advances in neurobehavioural toxicology: applications in environmental and occupational health. Chelsea, MI: Michigan Lewis Publishers; 1990. pp. 353–376. [Google Scholar]
66. Stollery BT, Banks HA, Broadbent DE, Lee WR. Cognitive functioning in lead workers. Br J Ind Med. 1989;46:698–707. [PMC free article] [PubMed] [Google Scholar]
67. Hanninen H, Aitio A, Kovala T, Luukkonen R, Matikainen E, Mannelin T, et al. Occupational exposure to lead and neuropsychological dysfunction. Occup Environ Med. 1998;55:202–209. [PMC free article] [PubMed] [Google Scholar]
68. Baker EL, White RF, Pothier LJ, Berkey CS, Dinse GE, Travers PH, et al. Occupational lead neurotoxicity: improvement in behavioural effects after reduction of exposure. Br J Ind Med. 1985;42:507–516. [PMC free article] [PubMed] [Google Scholar]
69. Renner R. Exposure on tap: drinking water as an overlooked source of lead. Environ Health Perspect. 2010;118:A68–A72. [PMC free article] [PubMed] [Google Scholar]
70. Schoeters G, Hond ED, Dhooge W, Larebeke NV, Leijs M. Endocrine disruptors and abnormalities of pubertal development. Basic Clin Pharmacol & Toxicol. 2008;102:168–175. [PubMed] [Google Scholar]
71. Borja-Aburto VH, Hertz-Picciotto I, Rojas Lopez M, Farias P, Rios C, Blanco J. Blood lead levels measured prospectively and risk of spontaneous abortion. Am J Epidemiol. 1999;150:590–597. [PubMed] [Google Scholar]
72. Zhang H, Liu Y, Zhang R, Liu R, Chen Y. Binding mode investigations on the interaction of lead (II) Acetate with human chorionic gonadotropin. J Phys Chem B. 2014;118:9644–9650. [PubMed] [Google Scholar]
73. Health Protection Agency . Lead toxicological overview. Version 3. London: H.P.A; 2012. [Google Scholar]
74. Hu H. Knowledge of diagnosis and reproductive history among survivors of childhood plumbism. Am J Public Health. 1991;81:1070–1072. [PMC free article] [PubMed] [Google Scholar]
75. Saleh HA, El-Aziz GA, El-Fark MM, El-Gohary M. Effect of maternal lead exposure on craniofacial ossification in rat fetuses and the role of antioxidant therapy. Anat Histol Embryol. 2009;38:392–399. [PubMed] [Google Scholar]
76. Wadi S, Ahmad G. Effects of lead on the male reproductive system in mice. J Toxicol Environ Health A. 1999;56:513–521. [PubMed] [Google Scholar]
77. Telisman S, Cvitkovic P, Jurasovic J, Pizent A, Gavella M, Rocic B. Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. Environ Health Perspect. 2000;108:45. [PMC free article] [PubMed] [Google Scholar]
78. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease-a systematic review. Environ Health Perspect. 2007;115:472–482. [PMC free article] [PubMed] [Google Scholar]
79. Yu CC, Lin JL, Lin-Tan DT. Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol. 2004;15:1016–1022. [PubMed] [Google Scholar]
80. Carmignani M, Volpe AR, Boscolo P, Qiao N, DiGioacchino M, Grilli A, et al. Catcholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment. Life Sci J. 2000;68:401–415. [PubMed] [Google Scholar]
81. Finley J. Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation. U. S. Patent No.8, 652, 518.U. S. Patent and Trademark Office, Washington, DC; 2014.
82. Nisar MF, Nasir I, Shaheen S, Khalid A, Tazeen N. Chronic lead acetate nephrotoxicity: a histological study on albino rats. Ann King Edw Med Univ. 2014;17:239. [Google Scholar]
83. Gerhardsson L, Chettle DR, Englyst V, Nordberg GF, Nyhlin H, Scott MC, et al. Kidney effects in long term exposed lead smelter workers. Br J Ind Med. 1992;49:186–192. [PMC free article] [PubMed] [Google Scholar]
84. Ehrlich R, Robins T, Jordaan E, Miller S, Mbuli S, Selby P, et al. Lead absorption and renal dysfunction in a South African battery factory. Occup Environ Med. 1998;55:453–460. [PMC free article] [PubMed] [Google Scholar]
85. Staessen JA, Lauwerys RR, Buchet JP, Bulpitt CJ, Rondia D, Vanrenterghem Y, et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med. 1992;327:151–156. [PubMed] [Google Scholar]
86. Tsaih SW, Korrick S, Schwartz J, Amarasiriwardena C, Aro A, Sparrow D, et al. Lead, diabetes, hypertension, and renal function: the normative aging study. Environ Health Perspect. 2004;112:1178–1182. [PMC free article] [PubMed] [Google Scholar]
87. Needleman H. Lead poisoning. Annu Rev Med. 2004;55:209–222. [PubMed] [Google Scholar]
88. Glenn BS, Stewart WF, Schwartz BS, Bressler J. Relation of alleles of the sodium potassium adenosine triphosphatase alpha 2 gene with blood pressure and lead exposure. Am J Epidemiol. 2001;153:537–545. [PubMed] [Google Scholar]
89. Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the normative aging study. Am J Epidemiol. 2001;153:164–171. [PubMed] [Google Scholar]
90. Vupputuri S, He J, Muntner P, Bazzano LA, Whelton PK, Batuman V. Blood lead level is associated with elevated blood pressure in blacks. Hypertension. 2003;41:463–468. [PubMed] [Google Scholar]
91. Statement on the 2006 UK Total Diet Study of Metals and Other Elements. Committee on Toxicity of Chemicals in Food Consumer Products and the Environment (COT). London: Food Standards Agency; 2008.
92. International Agency for the Research on Cancer (IARC). Inorganic and organic lead compounds. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 87. Lyon, France; 2006.
93. Fayerweather WE, Karns ME, Nuwayhid IA, Nelson TJ. Case-control study of cancer risk in tetraethyl lead manufacturing. Am J Ind Med. 1997;3:28–35. [PubMed] [Google Scholar]
94. National Toxicity Program. Department of Health and Human Carcinogens. 12th ed. Department of Health and Human Services US; 2011.
95. Lundstrom NG, Nordberg G, Englyst V, Gerhardsson L, Hagmar L, Jin T, et al. Cumulative lead exposure in relation to mortality and lung cancer morbidity in a cohort of primary smelter workers. Scand J Work Environ Health. 1997;23:24–30. [PubMed] [Google Scholar]
96. Wynant W, Siemiatycki J, Parent ME, Rousseau MC. Occupational exposure to lead and lung cancer: results from two case-control studies in Montreal, Canada. Occup Environ Med. 2013;70:164–170. [PubMed] [Google Scholar]
97. Wetmur JG, Kaya AH, Plewinska M, Desnick RJ. Molecular characterization of the human -aminolevulinatedehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet. 1991;49:757–763. [PMC free article] [PubMed] [Google Scholar]
98. Schwartz BS, Lee BK, Stewart W, Ahn KD, Springer K, Kelsey K. Associations of δ-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol. 1995;142:738–745. [PubMed] [Google Scholar]
99. Agency for Toxic Substances and Disease Registry . Interaction profile for chlorpyrifos, lead, mercury, and methyl mercury. Atlanta, GA: United State Department of Health and Human Services; 2006. [Google Scholar]
100. Jain NB, Laden F, Guller U, Shankar A, Kazani S, Garshick E. Relation between blood lead levels and childhood anemia in India. Am J Epidemiol. 2005;161:968–973. [PubMed] [Google Scholar]
101. Schwartz BS, Lee BK, Lee GS, Stewart WF, Simon D, Kelsey K, et al. Associations of blood lead, dimercaptosuccinic acid chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta] aminolevulinic acid dehydratase genes. Environ Health Perspect. 2000;108:949–954. [PMC free article] [PubMed] [Google Scholar]
102. Piomelli S. Childhood lead poisoning. Pediatr Clin North Am J. 2002;49:1285–1304. [PubMed] [Google Scholar]
103. Kumar A, Prasad MNV, Achary VMM, Panda BB. Elucidation of lead-induced oxidative stress in Talinumtriangulare roots by analysis of antioxidant responses and DNA damage at cellular level. Environ Sci Pollut Res. 2013;20:4551–4561. [PubMed] [Google Scholar]
104. Flora SJS, Pachauri V. Chelation in metal intoxication. Int J Environ Res Public Health. 2010;7:2745–2788. [PMC free article] [PubMed] [Google Scholar]
105. Wang C, Liang J, Zhang C, Bi Y, Shi X, Shi Q. Effect of ascorbic acid and thiamine supplementation at different concentrations on lead toxicity in liver. Ann Occup Hyg. 2007;51:563–569. [PubMed] [Google Scholar]
106. Kim JS, Hamilton DL, Blakley BR, Roussraux CG. The effects of thiamine on lead metabolism: organ distribution of lead. Can J Vet Res. 1992;56:256–259. [PMC free article] [PubMed] [Google Scholar]
107. Najarnezhad V, Aslani MR, Balali-Mood M. The therapeutic potential of thiamine for treatment of experimentally induced sub-acute lead poisoning in sheep. Comp Clin Patol. 2010;19:69–73. [Google Scholar]
108. Sajitha GR, Jose R, Andrews A, Ajantha KG, Augustine P, Augusti KT, et al. Garlic oil and vitamin E prevent the adverse effects of lead acetate and ethanol separately as well as in combination in the drinking water of rats. Indian J Clin Biochem. 2010;25:280–288. [PMC free article] [PubMed] [Google Scholar]
109. Caylak E, Aytekin M, Halifeoglu I. Antioxidant effects of methionine, alpha-lipoic acid, N-acetylcysteine and homocysteine on lead-induced oxidative stress to erythrocytes in rats. Exp Toxicol Pathol. 2008;60:289–294. [PubMed] [Google Scholar]
110. Chen W, Ercal N, Huynh T, Volkov A, Chusuei CC. Characterizing N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) binding for lead poisoning treatment. J Colloid Interface Sci. 2012;371:144–149. [PMC free article] [PubMed] [Google Scholar]
111. Flora SJ, Pande M, Bhadauria S, Kannan GM. Combined administration of taurine and meso 2, 3 dimercaptosuccinic acid in the treatment of chronic lead intoxication in rats. Hum Exp Toxicol. 2004;23:157–166. [PubMed] [Google Scholar]
112. Kianoush S, Balali-Mood M, Mousavi SR, Moradi V, Sadeghi M, Dadpour B, et al. Comparison of therapeutic effects of garlic and d-Penicillamine in patients with chronic occupational lead poisoning. Basic Clin Pharmacol Toxicol. 2012;110:476–481. [PubMed] [Google Scholar]
113. Deldar K, Nazemi E, Balali MM, Emami SA, MohammadPour AH, Tafaghodi M, et al. Effect of Coriandrum sativum L. extract on lead excretion in 3-7 year old children. J Birjand Univ Med Sci. 2008;15:11–19. [Google Scholar]
114. Venkatesh T. Lead is hampering the Quality of our lives. In: Gyani GJ, editor. Quality India. 2008. pp. 22–23. [Google Scholar]
115. van Alphen M. Lead poisoning in India. LEAD Action News 1999;7(1):2–3.
116. Singh AK, Singh M. Lead decline in the Indian environment resulting from the petrol-lead phase-out programme. Sci Total Environ. 2006;368:686–694. [PubMed] [Google Scholar]
117. Maya C. Lead poisoning: warning bells toll. The Hindu. Updated on Aug 22, 2011.
118. Mitra P. Lead poisoning affects 20% Kolkata kids. Times of India; Jul 14, 2013.
119. Regulation on Lead contents in Household and Decorative Paints Rules, 2016. The Gazzette of India, Ministry of Environment, Forest and Climate Change notification, New Delhi; Nov 1, 2016.
120. Chatterjee P. Explained: the controversy surrounding Maggi Noodles. Indian Express Updated on Jun 5, 2015.
121. After Maggi and Knorr, Top Ramen noodles withdrawn from market. Hindustan times Updated on Jun 30, 2015.
122. New stocks of Maggi noodles cleared by labs, likely to hit stores this month: Nestle. Indian Express. Updated on Nov 4, 2015.
124. Chey H, Buchanan S. Toxins in everyday life. Prim Care. 2008;35:707–727. [PubMed] [Google Scholar]
125. Warniment C, Tsang K, Galazka SS. Lead poisoning in children. Am Fam Physician. 2010;81:751–757. [PubMed] [Google Scholar]
126. Woolf AD, Goldman R, Bellinger DC. Update on the clinical management of childhood lead poisoning. Pediatr Clin North Am. 2007;54:271–294. [PubMed] [Google Scholar]
127. Levin R, Brown MJ, Kashtock ME, Jacobs E, Whelan EA, Rodman J, et al. Lead exposures in U.S. Children, 2008: implications for prevention. Environ Health Perspect. 2008;2008(116):1285–1293. [PMC free article] [PubMed] [Google Scholar]
128. Shaik AP, Sultana SA, Alsaeed AH. Lead exposure: a summary of global studies and the need for new studies from Saudi Arabia. Dis Markers. 2014;2014:415160–415166. [PMC free article] [PubMed] [Google Scholar]